MS: Busting the Myths
August 22, 2019 | Education, Event, Life with MS, Treatments
MS Taranaki NED TALKS on Brain Health: Time Matters Saturday 31st August, 10am to 3pm (lunch included) at Plymouth International (Quality Hotel), 220 Courtenay Street, New Plymouth. Hosted by Graham Walker, President MS Taranaki Inc with invited guests from the […]
August 9, 2019 | Life with MS, Treatments
Pharmac announced on Wednesday 7th August, that they are now publicly consulting on the proposed funding of Ocrelizumab for Relapsing Remitting MS. MSNZ welcomes this announcement which we have been advocating for since May 2017. To read more about our […]
April 16, 2019 | Treatments
The European Medicines Agency (EMA) announced on the 12th April it is conducting a review into the safety of MS drug alemtuzumab (Lemtrada). The EMA has launched the safety review ‘following new reports of immune-mediated conditions (caused by the body’s […]
June 28, 2018 | Advocacy, Support, Treatments, Uncategorised
In 2017 MSNZ officially endorsed ‘Brain Health: time matters in MS’ , an international consensus report providing recommendations on diagnosis, therapeutic strategies and improving access to treatment in MS. Since then we have used the principles to direct and provide international […]
June 14, 2018 | Advocacy, Research, Treatments
On Monday 28th May Multiple Sclerosis New Zealand (MSNZ) with Professor Helmut Butzkueven, of Monash University in Melbourne, met with members of PHARMAC staff to discuss our continued concerns with the very restrictive access criteria for MS disease modifying treatments […]